超声引导下穿刺注射无水乙醇加口服米非司酮治疗腹壁切口子宫内膜异位症的疗效评价

Effects of Mifestone and Puncture treatment on abdominal incision endometriosis

目的探讨超声引导下穿刺注射无水乙醇加口服米非司酮治疗腹壁切口子宫内膜异位症的疗效。方法回顾分析我院2009年8月至2011年3月共收治腹壁切口子宫内膜异位症患者65例,随机分为两组,其中治疗组(即采用经超声引导下穿刺注射无水乙醇加口服米非司酮组)33例,对照组(即单用经超声引导下穿刺注射无水乙醇组)32例,比较两组的疗效及复发率。结果穿刺后两组异位结节及症状均消失而痊愈,复发率方面65例随访60例(5例失去随访),随访1年,治疗组及对照组复发率各为10(3/31)及38(11/29),两组间比较差异有统计学意义(P<0.01)。结论超声引导下穿刺注射无水乙醇加口服米非司酮治疗腹壁切口子宫内膜异位症优于单用超声引导下穿刺注射无水乙醇治疗腹壁切口子宫内膜异位症,并且副作用及创伤小,复发率低,值得推广。

Objective To study the effects of abdominal incision endometriosis treated by Mifestone and ultrasonographic guidance Puncture.Methods From August 2009 to March 2011,65 cases of abdominal incision endometriosis were randomly divided into two groups,33 cases of the treatment group treated by ultrasonographic guidance Puncture and Mifestone,32 cases of the control group treated by ultrasonographic guidance Puncture,and were followed up for 1 year.Results Two groups after Puncture,the symptoms disappeared and recovered.The treatment group and control group reoccurrence rates were 10%（3/31） and 38%（11/29）,the difference between the two groups was significant（P0.01）.Conclusion The combination of ultrasonographic guidance Puncture and oral Mifestone is safe and effective in the treatment of abdominal incision endometriosis and easy to operate,and Mifestone can prevent recurrence effectively.